Warner Chilcott UK Limited - arama sonuçları

nucare pharmaceuticals, inc. - fluoxetine hydrochloride (unii: i9w7n6b1kj) (fluoxetine - unii:01k63sup8d) - fluoxetine is indicated for the treatment of: · acute and maintenance treatment of major depressive disorder [see clinical studies (14.1)] . · acute and maintenance treatment of obsessions and compulsions in patients with obsessive compulsive disorder (ocd) [see clinical studies (14.2)]. · acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe bulimia nervosa [see clinical studies (14.3)] . · acute treatment of panic disorder, with or without agoraphobia [see clinical studies (14.4)]. fluoxetine and olanzapine in combination is indicated for the treatment of: · acute treatment of depressive episodes associated with bipolar i disorder in adult. fluoxetine monotherapy is not indicated for the treatment of depressive episodes associated with bipolar i disorder or the treatment of treatment resistant depression. when using fluoxetine and olanzapine in combination, also refer to the clinical studies section of the package

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

gabapentin 400mg capsules

mawdsley-brooks & company ltd - gabapentin - oral capsule - 400mg

İrlanda - İngilizce - HMA (Heads of Medicines Agencies)

excis cutaneous solution 10 g/l

vericore ltd - permethrin 1 w/v - cutaneous solution - fish food - cypermethrin

Birleşik Krallık - İngilizce - HMA (Heads of Medicines Agencies)

excis

vericore ltd - permethrin 1 w/v - cutaneous solution - fish food - cypermethrin